"Method Of Treating, Ameliorating And/Or Preventing Depression" in Patent Application Approval Process (USPTO 20230346718).
In: Drug Week, 2023-11-24, S. 3042-3042
serialPeriodical
Zugriff:
A patent application has been filed for a method of treating depression using a compound called dimethyltryptamine (DMT). The method involves administering the DMT compound to a subject in need of treatment, either intravenously or through other means, in specific dosages. The invention aims to provide a novel treatment method for depression, particularly for treatment-resistant cases. The DMT compound is not mixed with any other hallucinogenic or psychedelic agents, and the treatment does not require the use of monoamine oxidase inhibitors (MAOIs). The patent application also includes information about a kit for administering the DMT compound, which includes instructions for use. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Method Of Treating, Ameliorating And/Or Preventing Depression" in Patent Application Approval Process (USPTO 20230346718).
|
---|---|
Zeitschrift: | Drug Week, 2023-11-24, S. 3042-3042 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Schlagwort: |
|
Sonstiges: |
|